Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease

Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease

Background Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease and its prevalence has risen sharply. However, whether nutrition, dietary strategies, exercise, lifestyle and environment have preventive value for NAFLD remains unclear.Methods Through searching 4 databases (PubMed, Web...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiangyong Hao, Hao Song, Xin Su, Jian Li, Youbao Ye, Cailiu Wang, Xiao Xu, Guanglong Pang, Wenxiu Liu, Zihan Li, Tian Luo
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Annals of Medicine
Subjects:	Nonalcoholic fatty liver disease nutrition dietary strategies exercise lifestyle environment
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2464223
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease
by: K. A. Andreev, et al.
Published: (2022-01-01)

Ganoderma Sinense Soluble Dietary Fiber Alleviates Nonalcoholic Fatty Liver Disease by Regulating Liver Metabolism
by: Ping Shao, et al.
Published: (2025-08-01)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

Practical approaches to the nutritional management of nonalcoholic fatty liver disease
by: Leila Freidoony, et al.
Published: (2014-12-01)

Prospective cohort study of Helicobacter pylori infection on the risk of nonalcoholic fatty liver disease
by: Changxi Chen, et al.
Published: (2024-01-01)

Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes
by: Orsu Prabhakar, et al.
Published: (2021-01-01)

The impact of parity on the risk of nonalcoholic fatty liver disease defined by hepatic steatosis index: A nationwide cohort study
by: So-hyeon Hong, et al.
Published: (2025-07-01)

Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease
by: Min Tang, et al.
Published: (2020-01-01)

Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease
by: Suwei Jin, et al.
Published: (2025-01-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

Beyond medication: Unveiling the role of diet and lifestyle in fatty liver disease management
by: Iahtisham-Ul-Haq, et al.
Published: (2025-06-01)

Quality of Life in Patients with Nonalcoholic Fatty Liver Disease in Combination with Essential Hypertension
by: Mashura H., et al.
Published: (2015-09-01)

Gallstones increase the risk of nonalcoholic fatty liver: A case‐control study
by: Abdolreza Sheibani, et al.
Published: (2024-11-01)

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India
by: Sounak Sinha, et al.
Published: (2025-06-01)

Association between serum antibodies to oral microorganisms and nonalcoholic fatty liver disease in adults
by: Li Tan, et al.
Published: (2024-11-01)

Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study
by: Young Bin Cho, et al.
Published: (2025-07-01)

The Effect of Nonalcoholic Fatty Liver Disease on Extrahepatic Cancers: Evidence From Population‐Based Cohort and Mendelian Randomization
by: Wei Wang, et al.
Published: (2025-03-01)

Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan
by: Hao-Wen Liu, et al.
Published: (2020-01-01)

Adherence and barriers to Mediterranean diet in Tunisian patients with nonalcoholic fatty liver disease
by: Ayadi Shema, et al.
Published: (2024-12-01)

Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK–IDH2 pathway
by: Hao Huang, et al.
Published: (2023-04-01)

Waist to height ratio: a simple screening tool for nonalcoholic fatty liver disease in obese children
by: Bayram Özhan, et al.
Published: (2016-10-01)

Vegetarian diet, food substitution, and nonalcoholic fatty liver
by: Tina H Chiu, et al.
Published: (2018-01-01)

Pachymaran alleviates fat accumulation, hepatocyte degeneration, and injury in mice with nonalcoholic fatty liver disease
by: Yu Hong, et al.
Published: (2025-07-01)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023-06-01)

Oxidative stress and inflammation in hemodialysis: a comparison of patients with or without advanced nonalcoholic fatty liver disease (NAFLD)
by: Vanja Kalacun, et al.
Published: (2025-12-01)

Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study
by: Edgar Denova-Gutiérrez, et al.
Published: (2025-01-01)

The effects and mechanisms of Xiaoyao San on nonalcoholic fatty liver disease rat based on transcriptomics and proteomics analysis
by: Yunxiao Liu, et al.
Published: (2025-03-01)

Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: a systematic review and meta-analysis
by: Shaghayegh Khanmohammadi, et al.
Published: (2025-03-01)

Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysis
by: Cuihua Jiang, et al.
Published: (2025-04-01)

Platelet‐derived apoptotic vesicles ameliorate nonalcoholic fatty liver disease by regulating lipid metabolism via apolipoprotein A‐II
by: Yuhe Jiang, et al.
Published: (2025-01-01)

Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
by: Hua Jiang, et al.
Published: (2024-12-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Identification of immune and major depressive disorder-related diagnostic markers for early nonalcoholic fatty liver disease by WGCNA and machine learning
by: Yuyun Jia, et al.
Published: (2025-06-01)

Global Trends in Non-Invasive Techniques for the Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease: A Bibliometric and Visualization Analysis
by: Cai JW, et al.
Published: (2025-07-01)

Corrigendum: Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease
by: Hua Jiang, et al.
Published: (2025-04-01)

Serum uric acid and nonalcoholic fatty liver disease
by: Jia Fan, et al.
Published: (2024-11-01)

The causal impact of body mass index on metabolic biomarkers and nonalcoholic fatty liver disease risk
by: Bo Wang, et al.
Published: (2025-03-01)

Remnant cholesterol predicts the development of type 2 diabetes in patients with nonalcoholic fatty liver disease
by: Liping Yang, et al.
Published: (2025-07-01)